Opti Capital Management, LP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 40 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Opti Capital Management, LP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$46,902,000
+1.4%
46,902,0000.0%3.79%
-5.0%
Q4 2022$46,257,098
+0.9%
46,902,0000.0%3.99%
-6.0%
Q3 2022$45,824,000
+0.2%
46,902,0000.0%4.24%
-3.5%
Q2 2022$45,737,000
-1.5%
46,902,0000.0%4.40%
+17.6%
Q1 2022$46,433,000
+2.8%
46,902,000
+3.3%
3.74%
+9.2%
Q4 2021$45,147,000
+0.7%
45,402,0000.0%3.42%
-18.6%
Q3 2021$44,828,000
+21.0%
45,402,000
+21.6%
4.21%
+5.9%
Q2 2021$37,062,000
+2.0%
37,347,0000.0%3.97%
-10.4%
Q1 2021$36,345,000
-1.7%
37,347,000
-3.7%
4.44%
+7.7%
Q4 2020$36,963,000
-4.5%
38,801,000
-7.2%
4.12%
-13.0%
Q3 2020$38,713,000
+3.6%
41,818,000
+99876.1%
4.74%
-25.8%
Q2 2020$37,385,000
+10.9%
41,828
+2.0%
6.39%
-7.6%
Q1 2020$33,718,000
+287.5%
41,026
+329.1%
6.91%
+427.8%
Q4 2019$8,701,0009,5621.31%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Opti Capital Management, LP 45,402,000$44,828,0004.21%
Radcliffe Capital Management, L.P. 69,010,000$67,802,0001.97%
Penn Mutual Asset Management 675$672,0001.06%
CAMDEN ASSET MANAGEMENT L P /CA 24,548,000$24,118,0000.95%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,428,000$38,079,0000.87%
DeepCurrents Investment Group LLC 21,155,000$20,805,0000.62%
SHENKMAN CAPITAL MANAGEMENT INC 6,813,000$6,618,0000.51%
OAKTREE CAPITAL MANAGEMENT LP 22,348,000$22,068,0000.31%
WOLVERINE ASSET MANAGEMENT LLC 16,540,000$16,325,0000.14%
AVIVA PLC 17,300,000$16,926,0000.08%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders